These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28919008)

  • 1. Immunoadsorption in neurological disorders.
    Oji S; Nomura K
    Transfus Apher Sci; 2017 Oct; 56(5):671-676. PubMed ID: 28919008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoadsorption with regenerating systems in neurological disorders --A single center experience.
    Hohenstein B; Passauer J; Ziemssen T; Julius U
    Atheroscler Suppl; 2015 May; 18():119-23. PubMed ID: 25936315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic Apheresis in Neurological Disorders].
    Nakatsuji Y
    Brain Nerve; 2021 May; 73(5):425-430. PubMed ID: 34006672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
    Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
    Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
    Loschiavo C; Grecò M; Polo A; Del Colle R
    G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma exchange in neurological disease.
    Osman C; Jennings R; El-Ghariani K; Pinto A
    Pract Neurol; 2020 Apr; 20(2):92-99. PubMed ID: 31300488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmapheresis for neurological disorders.
    Schröder A; Linker RA; Gold R
    Expert Rev Neurother; 2009 Sep; 9(9):1331-9. PubMed ID: 19769448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma exchange and immunoadsorption for autoimmune neurologic diseases - current guidelines and future perspectives.
    Klingel R; Heibges A; Fassbender C
    Atheroscler Suppl; 2009 Dec; 10(5):129-32. PubMed ID: 20129391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoadsorption for autoimmune encephalitis.
    Fassbender C; Klingel R; Köhler W
    Atheroscler Suppl; 2017 Nov; 30():257-263. PubMed ID: 29096847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal antibody elimination in neuroimmunological diseases.
    Toepfer M; Schiffl H; Sitter T; Pongratz D; Müller-Felber W
    Ther Apher; 1999 Aug; 3(3):268-70. PubMed ID: 10427627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies--perspectives for immunoadsorption.
    Klingel R; Heibges A; Fassbender C
    Atheroscler Suppl; 2013 Jan; 14(1):161-5. PubMed ID: 23357159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic plasma exchange: applications in neurology].
    Láinez-Andrés JM; Gascón-Giménez F; Coret-Ferrer F; Casanova-Estruch B; Santonja JM
    Rev Neurol; 2015 Feb; 60(3):120-31. PubMed ID: 25624088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principles of Therapeutic Apheresis in Neurological Disease.
    Strasser E
    Transfus Med Hemother; 2023 Apr; 50(2):88-97. PubMed ID: 37066058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis.
    Ohkubo A; Okado T; Sakurasawa T; Maeda T; Itagaki A; Yamamoto H; Miyamoto S; Seshima H; Kurashima N; Mori T; Iimori S; Sohara E; Rai T; Uchida S; Naito S
    Ther Apher Dial; 2019 Jun; 23(3):271-278. PubMed ID: 31025833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
    Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
    Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoadsorption in steroid-refractory multiple sclerosis: clinical experience in 60 patients.
    Heigl F; Hettich R; Arendt R; Durner J; Koehler J; Mauch E
    Atheroscler Suppl; 2013 Jan; 14(1):167-73. PubMed ID: 23357160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoadsorption and plasma exchange-Efficient treatment options for neurological autoimmune diseases.
    Boedecker SC; Luessi F; Engel S; Kraus D; Klimpke P; Holtz S; Meinek M; Marczynski P; Weinmann A; Weinmann-Menke J
    J Clin Apher; 2022 Feb; 37(1):70-81. PubMed ID: 34904748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic plasma exchange in neurological disorders: Experience from a tertiary neuroscience centre.
    Das J; Chauhan VD; Mills D; Johal NJ; Tan M; Matthews R; Keh R; Lilleker JB; Gosal D; Sharaf N
    Transfus Apher Sci; 2019 Dec; 58(6):102654. PubMed ID: 31648858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan immunoadsorption for the treatment of autoimmune encephalitis.
    Köhler W; Ehrlich S; Dohmen C; Haubitz M; Hoffmann F; Schmidt S; Klingel R; Kraft A; Neumann-Haefelin T; Topka H; Stich O; Baumgartner A; Fassbender C
    Eur J Neurol; 2015 Jan; 22(1):203-6. PubMed ID: 24589025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Apheresis in Immunologic Renal and Neurological Diseases.
    Bambauer R; Latza R; Burgard D; Schiel R
    Ther Apher Dial; 2017 Feb; 21(1):6-21. PubMed ID: 28078733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.